The Column-08-07-2015

A team of researchers in Spain has examined the use of commercial yeast products in the production of white and rosé sparkling wines.

A team of chemists and microbiologists from the University of Leicester has developed a new method of rapidly diagnosing the infection Clostridium difficile (C. difficile).

The Column

Tetrahydrofuran (THF) - a widely used solvent in gel permeation chromatography/size-exclusion chromatography (GPC/SEC) - is set to be classified as carcinogenic as proposed by the Committee for Risk Assessment (RAC). Analytical laboratories therefore need to find ways to reduce THF solvent use and waste, far beyond the demands of green chemistry. This instalment of Tips & Tricks presents different strategies to meet this goal.

The Column

An excerpt from LCGC’s e-learning tutorial on high performance liquid chromatography (HPLC) methods for biomolecule analysis at CHROMacademy.com

The 43rd Symposium of HPLC and Related Techniques (HPLC 2015 Beijing Conference) will take place at the Beijing International Conference Centre, Beijing, People’s Republic of China, from 21–25 September 2015.

Click the title above to open The Column August 07, 2015 Europe & Asia issue, Volume 11, Number 14, in an interactive PDF format.

Click the title above to open The Column August 07, 2015 North American issue, Volume 11, Number 14, in an interactive PDF format.

The Column

Persistent organic pollutants (POPs) pose an on-going threat to human health, but are often trapped within environmental samples, thereby making analysis challenging. Bethany Degg of The Column spoke to Lourdes Ramos from the Department of Instrumental Analysis and Environmental Chemistry Institute of Organic Chemistry of the CSIC (Madrid, Spain) about her innovative research on new sample preparation methods for POPs.

Agilent Technologies Inc. has announced that Dr. Lawrence J. Lesko from the University of Florida’s College of Pharmacy in Orlando, USA, has received an Agilent Thought Leader Award for his research into preclinical toxicological assessments of new medicines.